Sai Life Sciences’ IPO, aiming to raise up to Rs 3,042 crore, includes a fresh equity issue of up to Rs 950 crore and an Offer for Sale of 3.81 crore shares. The price band is set at Rs 522-549 per share, with a minimum bid of 27 shares. The current GMP is Rs 22, signaling a 4.01% premium.
PB Fintech: Goldman Sachs, Tata Mutual Fund buy stake in Rs 695 crore block deal
PB Fintech shares witnessed block deals worth Rs 695 crore, with Goldman Sachs, mutual funds, and foreign investors acquiring shares from Tencent Cloud Europe, signaling